US company Hospira offers A$2.63 billion for Mayne Pharma
Merrill Lynch finds a foreign buyer for the Australian cancer drug specialist.
September 21, 2006
- News
-
Investment Lifecycle
Deals & Trends
Rainmakers
Regions
- Research
-
- Awards
-
- Events
- Photo Gallery
